Entry - #615916 - CARDIOMYOPATHY, DILATED, 1NN; CMD1NN - OMIM
# 615916

CARDIOMYOPATHY, DILATED, 1NN; CMD1NN


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
3p25.2 Cardiomyopathy, dilated, 1NN 615916 AD 3 RAF1 164760
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
CARDIOVASCULAR
Heart
- Dilated cardiomyopathy
- Decreased left ventricular ejection fraction
- Mitral regurgitation, mild to severe
- Ventricular arrhythmia (in some patients)
MISCELLANEOUS
- Onset in childhood or adolescence in most patients
MOLECULAR BASIS
- Caused by mutation in the v-raf-1 murine leukemia viral oncogene homolog-1 gene (RAF1, 164760.0005)
Dilated cardiomyopathy - PS115200 - 60 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Cardiomyopathy, dilated, 1LL AD 3 615373 PRDM16 605557
1p36.32 Left ventricular noncompaction 8 AD 3 615373 PRDM16 605557
1p34.2 Cardiomyopathy, dilated, 2C AR 3 618189 PPCS 609853
1p31.1 Cardiomyopathy, dilated, 1CC AD 3 613122 NEXN 613121
1q22 Cardiomyopathy, dilated, 1A AD 3 115200 LMNA 150330
1q32.1 Cardiomyopathy, dilated, 1D AD 3 601494 TNNT2 191045
1q32.1 Left ventricular noncompaction 6 AD 3 601494 TNNT2 191045
1q42.13 Cardiomyopathy, dilated, 1V AD 3 613697 PSEN2 600759
1q43 Cardiomyopathy, hypertrophic, 23, with or without LVNC AD 3 612158 ACTN2 102573
1q43 Cardiomyopathy, dilated, 1AA, with or without LVNC AD 3 612158 ACTN2 102573
2q14-q22 Cardiomyopathy, dilated, 1H 2 604288 CMD1H 604288
2q31.2 Cardiomyopathy, dilated, 1G AD 3 604145 TTN 188840
2q35 Cardiomyopathy, dilated, 1I AD 3 604765 DES 125660
3p25.2 Cardiomyopathy, dilated, 1NN AD 3 615916 RAF1 164760
3p22.2 Cardiomyopathy, dilated, 1E AD 3 601154 SCN5A 600163
3p21.1 Cardiomyopathy, dilated, 1Z AD 3 611879 TNNC1 191040
5p15.33 Cardiomyopathy, dilated, 1GG AR 3 613642 SDHA 600857
5q33.2-q33.3 Cardiomyopathy, dilated, 1L 3 606685 SGCD 601411
6p22.3 Cardiomyopathy, dilated, 2I AR 3 620462 CAP2 618385
6q12-q16 Cardiomyopathy, dilated, 1K 2 605582 CMD1K 605582
6q21 Cardiomyopathy, dilated, 1JJ AD 3 615235 LAMA4 600133
6q22.31 Cardiomyopathy, dilated, 1P 3 609909 PLN 172405
6q23.2 ?Cardiomyopathy, dilated, 1J AD 3 605362 EYA4 603550
7q21.2 ?Cardiomyopathy, dilated, 2B AR 3 614672 GATAD1 614518
7q22.3-q31.1 Cardiomyopathy, dilated, 1Q 2 609915 CMD1Q 609915
7q31.32 Cardiomyopathy, dilated, 2G AR 3 619897 LMOD2 608006
9q13 Cardiomyopathy, dilated 1B AD 2 600884 CMD1B 600884
9q31.2 Cardiomyopathy, dilated, 1X AR 3 611615 FKTN 607440
10q21.3 Cardiomyopathy, hypertrophic, 22 AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, dilated, 1KK AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, familial restrictive, 4 AD 3 615248 MYPN 608517
10q22.2 Cardiomyopathy, dilated, 1W 3 611407 VCL 193065
10q23.2 Left ventricular noncompaction 3 AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, dilated, 1C, with or without LVNC AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, hypertrophic, 24 AD 3 601493 LDB3 605906
10q25.2 Cardiomyopathy, dilated, 1DD AD 3 613172 RBM20 613171
10q26.11 Cardiomyopathy, dilated, 1HH AD 3 613881 BAG3 603883
11p15.1 ?Cardiomyopathy, dilated, 1M 3 607482 CSRP3 600824
11p11.2 Left ventricular noncompaction 10 AD 3 615396 MYBPC3 600958
11p11.2 Cardiomyopathy, dilated, 1MM AD 3 615396 MYBPC3 600958
11q23.1 Cardiomyopathy, dilated, 1II AD 3 615184 CRYAB 123590
12p12.1 Cardiomyopathy, dilated, 1O AD 3 608569 ABCC9 601439
14q11.2 Cardiomyopathy, dilated, 1EE AD 3 613252 MYH6 160710
14q11.2 Cardiomyopathy, dilated, 1S AD 3 613426 MYH7 160760
14q11.2 Left ventricular noncompaction 5 AD 3 613426 MYH7 160760
14q24.2 ?Cardiomyopathy, dilated, 1U AD 3 613694 PSEN1 104311
14q32.33 Cardiomyopathy, dilated, 2F AR 3 619747 BAG5 603885
15q14 Left ventricular noncompaction 4 AD 3 613424 ACTC1 102540
15q14 Cardiomyopathy, dilated, 1R AD 3 613424 ACTC1 102540
15q22.2 Cardiomyopathy, dilated, 1Y AD 3 611878 TPM1 191010
15q22.2 Left ventricular noncompaction 9 AD 3 611878 TPM1 191010
16p13.3 Cardiomyopathy, dilated, 2D AR 3 619371 RPL3L 617416
17p11.2 Cardiomyopathy, dilated, 2J AR 3 620635 FLII 600362
17q22 ?Cardiomyopathy, dilated, 1OO AD 3 620247 VEZF1 606747
18q12.1 Cardiomyopathy, dilated, 1BB AR 3 612877 DSG2 125671
19p13.13 ?Cardiomyopathy, dilated, 2H AR 3 620203 GET3 601913
19q13.42 ?Cardiomyopathy, dilated, 2A AR 3 611880 TNNI3 191044
19q13.42 Cardiomyopathy, dilated, 1FF 3 613286 TNNI3 191044
20q13.12 Cardiomyopathy, dilated, 2E AR 3 619492 JPH2 605267
Xp21.2-p21.1 Cardiomyopathy, dilated, 3B XL 3 302045 DMD 300377

TEXT

A number sign (#) is used with this entry because of evidence that dilated cardiomyopathy-1NN (CMD1NN) is caused by heterozygous mutation in the RAF1 gene (164760) on chromosome 3p25.

For a general phenotypic description and a discussion of genetic heterogeneity of dilated cardiomyopathy, see CMD1A (115200).


Clinical Features

Dhandapany et al. (2014) reported patients with nonsyndromic dilated cardiomyopathy (CMD) and mutations in the RAF1 gene (see MOLECULAR GENETICS). Of 10 patients in whom age of onset was known, 8 presented in childhood or adolescence. The average age at presentation was 12.6 years, which the authors noted was younger than the approximate average of 20 years associated with CMD caused by sarcomeric gene mutations.


Inheritance

The transmission pattern of dilated cardiomyopathy in the families reported by Dhandapany et al. (2014) was consistent with autosomal dominant inheritance.


Molecular Genetics

In 218 patients from South India with nonsyndromic dilated cardiomyopathy, Dhandapany et al. (2014) analyzed 9 RAS-MAPK genes and identified 4 heterozygous mutations in the RAF1 gene (see, e.g., 164760.0005 and 164760.0006) in 5 of the CMD probands. The RAF1 mutations were not found in 500 ancestry-matched controls or in 13,600 European and African American alleles in the Exome Sequencing Project database; in addition, the 5 probands were negative for mutation in 12 known cardiomyopathy genes. Dhandapany et al. (2014) screened 200 North Indian, 35 Japanese, and 60 Italian probands with CMD for mutations in RAF1 and identified 2 different heterozygous mutations in 2 North Indian patients (see, e.g., 164760.0006) and 2 in 2 Japanese patients (see, e.g., 164760.0007).


REFERENCES

  1. Dhandapany, P. S., Razzaque, M. A., Muthusami, U., Kunnoth, S., Edwards, J. J., Mulero-Navarro, S., Riess, I., Pardo, S., Sheng, J., Rani, D. S., Rani, B., Govindaraj, P., and 17 others. RAF1 mutations in childhood-onset dilated cardiomyopathy. Nature Genet. 46: 635-639, 2014. [PubMed: 24777450, images, related citations] [Full Text]


Creation Date:
Marla J. F. O'Neill : 7/30/2014
carol : 03/06/2024
carol : 08/01/2014
mcolton : 7/30/2014

# 615916

CARDIOMYOPATHY, DILATED, 1NN; CMD1NN


ORPHA: 154;   DO: 0110432;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
3p25.2 Cardiomyopathy, dilated, 1NN 615916 Autosomal dominant 3 RAF1 164760

TEXT

A number sign (#) is used with this entry because of evidence that dilated cardiomyopathy-1NN (CMD1NN) is caused by heterozygous mutation in the RAF1 gene (164760) on chromosome 3p25.

For a general phenotypic description and a discussion of genetic heterogeneity of dilated cardiomyopathy, see CMD1A (115200).


Clinical Features

Dhandapany et al. (2014) reported patients with nonsyndromic dilated cardiomyopathy (CMD) and mutations in the RAF1 gene (see MOLECULAR GENETICS). Of 10 patients in whom age of onset was known, 8 presented in childhood or adolescence. The average age at presentation was 12.6 years, which the authors noted was younger than the approximate average of 20 years associated with CMD caused by sarcomeric gene mutations.


Inheritance

The transmission pattern of dilated cardiomyopathy in the families reported by Dhandapany et al. (2014) was consistent with autosomal dominant inheritance.


Molecular Genetics

In 218 patients from South India with nonsyndromic dilated cardiomyopathy, Dhandapany et al. (2014) analyzed 9 RAS-MAPK genes and identified 4 heterozygous mutations in the RAF1 gene (see, e.g., 164760.0005 and 164760.0006) in 5 of the CMD probands. The RAF1 mutations were not found in 500 ancestry-matched controls or in 13,600 European and African American alleles in the Exome Sequencing Project database; in addition, the 5 probands were negative for mutation in 12 known cardiomyopathy genes. Dhandapany et al. (2014) screened 200 North Indian, 35 Japanese, and 60 Italian probands with CMD for mutations in RAF1 and identified 2 different heterozygous mutations in 2 North Indian patients (see, e.g., 164760.0006) and 2 in 2 Japanese patients (see, e.g., 164760.0007).


REFERENCES

  1. Dhandapany, P. S., Razzaque, M. A., Muthusami, U., Kunnoth, S., Edwards, J. J., Mulero-Navarro, S., Riess, I., Pardo, S., Sheng, J., Rani, D. S., Rani, B., Govindaraj, P., and 17 others. RAF1 mutations in childhood-onset dilated cardiomyopathy. Nature Genet. 46: 635-639, 2014. [PubMed: 24777450] [Full Text: https://doi.org/10.1038/ng.2963]


Creation Date:
Marla J. F. O'Neill : 7/30/2014

Edit History:
carol : 03/06/2024
carol : 08/01/2014
mcolton : 7/30/2014